The Outcomes of Living Donor Robotic Assisted Kidney Transplantation
NCT ID: NCT06577805
Last Updated: 2024-09-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
400 participants
OBSERVATIONAL
2020-07-01
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
RAKT OUTCOME ANALYSIS
NCT06320821
ABO-Incompatible Kidney Transplants Between Robot-Assisted vs. Open Surgery
NCT06287008
Study Investigating Whether Robot-assisted Surgery Can Reduce Surgical Complications Following Kidney Transplantation
NCT05730257
Minimally Invasive Kidney Transplantation
NCT03322709
Comparison of Robot-assisted Donornephrectomy vs Hand-assisted Laparoscopic Donornephrectomy
NCT05194280
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
grafts with a single artery (GSA)
recipients of grafts with a single artery undergoing living donor robotic-assisted kidney transplantation
No interventions assigned to this group
grafts with multiple single arteries (GMA)
recipients of grafts with multiple renal arteries undergoing living donor robotic-assisted kidney transplantation
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. receiving standard triad immunosuppressive regimen
Exclusion Criteria
2. multi-organ transplantation
3. malignancy history in the donor and recipient
4. human immunodeficiency virus infection
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
West China Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Tao Lin
Professor Tao Lin
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
West China Hospital, Sichuan University
Chengdu, Sichuan, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Tang Y, Zhang H, Yin S, Li Y, Zeng J, Lin T, Song T. The Early Outcomes of Robotic-Assisted Kidney Transplantation Using Grafts With Multiple Arteries From a High-Volume Center: A Retrospective Cohort Study. Clin Transplant. 2025 Oct;39(10):e70328. doi: 10.1111/ctr.70328.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
WestChina-RAKT
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.